SCHEMBL4143769

SCHEMBL4143769

CC(C)(C)c1cc(CO)cc(C=O)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
TSHR P16473 4/20 0.51
MAPT P10636 4/20 0.51
MAPK1 P28482 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
BLM P54132 2/20 0.51
ATM Q13315 2/20 0.51
HIF1A Q16665 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
USP2 O75604 1/20 0.51
CYP2D6 P10635 1/20 0.51
GSR P00390 2/20 0.46
LMNA P02545 4/20 0.46
GABBR2 O75899 2/20 0.46
GABBR1 Q9UBS5 2/20 0.46
GMNN O75496 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29475419 0.88 ALDH1A1 (0.50) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL917208 0.88 ALDH1A1 (0.50) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL2461602 0.88 ALDH1A1 (0.53) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL31489807 0.85 ALDH1A1 (0.50) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL19411066 0.81 ERN1 (0.54) MAPTLMNAKDM4EERN1
SCHEMBL42656 0.81 ALDH1A1 (0.64) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL4141395 0.81 ALDH1A1 (0.43) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL12904884 0.80 ALDH1A1 (0.51) ALDH1A1TSHRMAPTMAPK1MEN1
SCHEMBL15151745 0.80 GAA (0.46) ALDH1A1TSHRMAPTMAPK1MEN1
Boric Acid SCHEMBL28025581 0.80 ALDH1A1 (0.58) ALDH1A1TSHRMAPTMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207365-B2 Polymeric salen compounds and methods thereof GEORGIA TECH RESEARCH CORPORATION (US) 2012-06-26 US disclosed
US-20090030172-A1 POLYMERIC SALEN COMPOUNDS AND METHODS THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030172-A1 POLYMERIC SALEN COMPOUNDS AND METHODS THEREOF F12, CHRM1, H1-0 ALDH1A1 1087/4885TSHR 3973/4885MAPT 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.